Your Messages Inbox
Your Article Summary
See Latest ArticlesMediGene Spins Out mTCR Programme - Independent Company Immunocore Limited Founded
MediGene, 10/06/08
MediGene AG and three private investors have founded Immunocore Ltd, which will focus on the technology platform for monoclonal T-cell receptors (mTCR) of MediGene's UK subsidiary MediGene Ltd. MediGene holds a 38.5% stake in Immunocore Ltd and will be the largest shareholder of the new company.
| Previous Article | Next Article |
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Spherix announces full-scale production of pharmaceutical tagatose
Spherix, 06/24/09
Thermophilic ethanologenesis: future prospects for second-generation bioethanol production
Trends in Biotechnology , 06/30/09
Antiplasmodial activity of extracts from seven medicinal plants used in malaria treatment in Cameroon
Journal of Ethnopharmacology , 06/15/09
Article Search
Sponsor